Salió en la lista "The 5 Worst Drug Companies of 2009"
y a la hora de los loros...
"Genzyme Corp.’s embattled chief executive, Henri A. Termeer, did not receive a bonus last year because of production problems at the company’s Allston Landing plant. But Termeer still drew total compensation of $9.5 million, 25 percent below his 2008 compensation, according to a proxy statement filed yesterday by the Cambridge biotechnology company."
.../...
Tampoco sale tan mal parado...
"The bulk of Termeer’s compensation for 2009, almost $7.7 million, was in restricted stock and stock options that will vest over time. The Genzyme board’s compensation committee “believes it is appropriate for equity awards to comprise a significant portion of Mr. Termeer’s total compensation,’’ citing compensation data for chief executives at peer companies, the proxy statement said.
Termeer also received a salary of $1.7 million, up from $1.6 million the prior year, and retirement savings contributions of $124,000, up from $115,000. But while he received a $1.9 million bonus in 2008, he was not awarded any bonus money for last year. (Ver...)
Entradas
No hay comentarios:
Publicar un comentario